ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 18 Issue : 5 Year: 2017
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Antithrombotics (Antithrombin therapy) [Anatol J Cardiol]
Anatol J Cardiol. 2006; 6(Suppl 1): 20-24

Antithrombotics (Antithrombin therapy)

Serdar Payzin1
Ege Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, İzmir, Türkiye

Thrombus on the atherosclerotic plaque is mainly responsible for acute coronary syndromes. Antithrombin therapy continues to be the mainstay of the therapy defeating thrombus. Up-to-date antithrombin therapy consists of vitamin K antagonists, unfractionated and low molecular heparins, direct thrombin inhibitors and selective inhibitors of factor Xa. Today, none of these drugs is effective enough in every aspect. The need for new antithrombin drugs, as well as the need for new antiplatelet drugs which can be safely and effectively used to- gether with other antithrombin drugs, persists.

Keywords: Acute coronary syndrome, thrombus, antithrombin therapy


Serdar Payzin. Antithrombotics (Antithrombin therapy). Anatol J Cardiol. 2006; 6(Suppl 1): 20-24


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2016 Turkish Society of Cardiology